Logo image of ALBFR.PA

SIDETRADE (ALBFR.PA) Stock Fundamental Analysis

EPA:ALBFR - Euronext Paris - Matif - FR0010202606 - Common Stock - Currency: EUR

242  -3 (-1.22%)

Fundamental Rating

6

Overall ALBFR gets a fundamental rating of 6 out of 10. We evaluated ALBFR against 101 industry peers in the Software industry. ALBFR has outstanding health and profitabily ratings, belonging to the best of the industry. This is a solid base for any company. ALBFR is valued quite expensive, but it does show an excellent growth. These ratings would make ALBFR suitable for growth and quality investing!


Dividend Valuation Growth Profitability Health

8

1. Profitability

1.1 Basic Checks

In the past year ALBFR was profitable.
ALBFR had a positive operating cash flow in the past year.
ALBFR had positive earnings in each of the past 5 years.
In the past 5 years ALBFR always reported a positive cash flow from operatings.
ALBFR.PA Yearly Net Income VS EBIT VS OCF VS FCFALBFR.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2M 4M 6M 8M

1.2 Ratios

Looking at the Return On Assets, with a value of 10.30%, ALBFR belongs to the top of the industry, outperforming 91.09% of the companies in the same industry.
The Return On Equity of ALBFR (20.04%) is better than 85.15% of its industry peers.
ALBFR has a Return On Invested Capital of 8.78%. This is in the better half of the industry: ALBFR outperforms 70.30% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for ALBFR is below the industry average of 10.93%.
The 3 year average ROIC (8.57%) for ALBFR is below the current ROIC(8.78%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 10.3%
ROE 20.04%
ROIC 8.78%
ROA(3y)8.09%
ROA(5y)8.31%
ROE(3y)16.87%
ROE(5y)17.25%
ROIC(3y)8.57%
ROIC(5y)9.37%
ALBFR.PA Yearly ROA, ROE, ROICALBFR.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20

1.3 Margins

With a decent Profit Margin value of 14.36%, ALBFR is doing good in the industry, outperforming 73.27% of the companies in the same industry.
ALBFR's Profit Margin has improved in the last couple of years.
ALBFR has a Operating Margin of 10.56%. This is in the better half of the industry: ALBFR outperforms 65.35% of its industry peers.
ALBFR's Operating Margin has improved in the last couple of years.
ALBFR has a Gross Margin of 75.67%. This is in the better half of the industry: ALBFR outperforms 61.39% of its industry peers.
ALBFR's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 10.56%
PM (TTM) 14.36%
GM 75.67%
OM growth 3Y-11.7%
OM growth 5Y3.49%
PM growth 3Y-0.3%
PM growth 5Y10.94%
GM growth 3Y2.02%
GM growth 5Y2.88%
ALBFR.PA Yearly Profit, Operating, Gross MarginsALBFR.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60

7

2. Health

2.1 Basic Checks

ALBFR has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
Compared to 1 year ago, ALBFR has more shares outstanding
Compared to 5 years ago, ALBFR has more shares outstanding
ALBFR has a better debt/assets ratio than last year.
ALBFR.PA Yearly Shares OutstandingALBFR.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200K 400K 600K 800K 1M
ALBFR.PA Yearly Total Debt VS Total AssetsALBFR.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

2.2 Solvency

ALBFR has an Altman-Z score of 7.84. This indicates that ALBFR is financially healthy and has little risk of bankruptcy at the moment.
ALBFR has a Altman-Z score of 7.84. This is in the better half of the industry: ALBFR outperforms 76.24% of its industry peers.
The Debt to FCF ratio of ALBFR is 0.92, which is an excellent value as it means it would take ALBFR, only 0.92 years of fcf income to pay off all of its debts.
ALBFR's Debt to FCF ratio of 0.92 is amongst the best of the industry. ALBFR outperforms 83.17% of its industry peers.
A Debt/Equity ratio of 0.20 indicates that ALBFR is not too dependend on debt financing.
ALBFR's Debt to Equity ratio of 0.20 is fine compared to the rest of the industry. ALBFR outperforms 66.34% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.2
Debt/FCF 0.92
Altman-Z 7.84
ROIC/WACC1.04
WACC8.43%
ALBFR.PA Yearly LT Debt VS Equity VS FCFALBFR.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M 20M 30M

2.3 Liquidity

A Current Ratio of 1.55 indicates that ALBFR should not have too much problems paying its short term obligations.
The Current ratio of ALBFR (1.55) is better than 64.36% of its industry peers.
ALBFR has a Quick Ratio of 1.55. This is a normal value and indicates that ALBFR is financially healthy and should not expect problems in meeting its short term obligations.
The Quick ratio of ALBFR (1.55) is better than 66.34% of its industry peers.
Industry RankSector Rank
Current Ratio 1.55
Quick Ratio 1.55
ALBFR.PA Yearly Current Assets VS Current LiabilitesALBFR.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M

8

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 40.62% over the past year.
Measured over the past years, ALBFR shows a very strong growth in Earnings Per Share. The EPS has been growing by 27.85% on average per year.
ALBFR shows a strong growth in Revenue. In the last year, the Revenue has grown by 25.69%.
The Revenue has been growing by 16.43% on average over the past years. This is quite good.
EPS 1Y (TTM)40.62%
EPS 3Y16.56%
EPS 5Y27.85%
EPS Q2Q%22.96%
Revenue 1Y (TTM)25.69%
Revenue growth 3Y19.06%
Revenue growth 5Y16.43%
Sales Q2Q%31.95%

3.2 Future

ALBFR is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 12.12% yearly.
Based on estimates for the next years, ALBFR will show a quite strong growth in Revenue. The Revenue will grow by 15.06% on average per year.
EPS Next Y10.56%
EPS Next 2Y12.12%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year16.24%
Revenue Next 2Y15.06%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
ALBFR.PA Yearly Revenue VS EstimatesALBFR.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 20M 40M 60M
ALBFR.PA Yearly EPS VS EstimatesALBFR.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2020 2021 2022 2023 2024 2025 2026 2 4 6

3

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 46.54 indicates a quite expensive valuation of ALBFR.
Compared to the rest of the industry, the Price/Earnings ratio of ALBFR indicates a somewhat cheap valuation: ALBFR is cheaper than 64.36% of the companies listed in the same industry.
When comparing the Price/Earnings ratio of ALBFR to the average of the S&P500 Index (27.30), we can say ALBFR is valued expensively.
With a Price/Forward Earnings ratio of 40.79, ALBFR can be considered very expensive at the moment.
Compared to the rest of the industry, the Price/Forward Earnings ratio of ALBFR is on the same level as its industry peers.
ALBFR's Price/Forward Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 21.76.
Industry RankSector Rank
PE 46.54
Fwd PE 40.79
ALBFR.PA Price Earnings VS Forward Price EarningsALBFR.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

ALBFR's Enterprise Value to EBITDA is on the same level as the industry average.
Based on the Price/Free Cash Flow ratio, ALBFR is valued a bit cheaper than 66.34% of the companies in the same industry.
Industry RankSector Rank
P/FCF 42.37
EV/EBITDA 48.55
ALBFR.PA Per share dataALBFR.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
The excellent profitability rating of ALBFR may justify a higher PE ratio.
ALBFR's earnings are expected to grow with 12.12% in the coming years. This may justify a more expensive valuation.
PEG (NY)4.41
PEG (5Y)1.67
EPS Next 2Y12.12%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

ALBFR does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

SIDETRADE

EPA:ALBFR (7/11/2025, 7:00:00 PM)

242

-3 (-1.22%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)04-15 2025-04-15
Earnings (Next)07-16 2025-07-16
Inst Owners18.26%
Inst Owner ChangeN/A
Ins Owners35.29%
Ins Owner ChangeN/A
Market Cap363.00M
Analysts84
Price Target290.7 (20.12%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)3.64%
PT rev (3m)3.64%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)1.05%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-1.55%
Valuation
Industry RankSector Rank
PE 46.54
Fwd PE 40.79
P/S 6.6
P/FCF 42.37
P/OCF 37.94
P/B 9.21
P/tB 42.07
EV/EBITDA 48.55
EPS(TTM)5.2
EY2.15%
EPS(NY)5.93
Fwd EY2.45%
FCF(TTM)5.71
FCFY2.36%
OCF(TTM)6.38
OCFY2.64%
SpS36.65
BVpS26.27
TBVpS5.75
PEG (NY)4.41
PEG (5Y)1.67
Profitability
Industry RankSector Rank
ROA 10.3%
ROE 20.04%
ROCE 11.95%
ROIC 8.78%
ROICexc 18.16%
ROICexgc N/A
OM 10.56%
PM (TTM) 14.36%
GM 75.67%
FCFM 15.58%
ROA(3y)8.09%
ROA(5y)8.31%
ROE(3y)16.87%
ROE(5y)17.25%
ROIC(3y)8.57%
ROIC(5y)9.37%
ROICexc(3y)18.44%
ROICexc(5y)20.75%
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)11.66%
ROCE(5y)12.74%
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3Y-1.75%
ROICexc growth 5Y5.4%
OM growth 3Y-11.7%
OM growth 5Y3.49%
PM growth 3Y-0.3%
PM growth 5Y10.94%
GM growth 3Y2.02%
GM growth 5Y2.88%
F-Score7
Asset Turnover0.72
Health
Industry RankSector Rank
Debt/Equity 0.2
Debt/FCF 0.92
Debt/EBITDA 1.09
Cap/Depr 71.02%
Cap/Sales 1.82%
Interest Coverage 250
Cash Conversion 132.6%
Profit Quality 108.49%
Current Ratio 1.55
Quick Ratio 1.55
Altman-Z 7.84
F-Score7
WACC8.43%
ROIC/WACC1.04
Cap/Depr(3y)191.5%
Cap/Depr(5y)202.1%
Cap/Sales(3y)4.08%
Cap/Sales(5y)4.13%
Profit Quality(3y)97.77%
Profit Quality(5y)121.95%
High Growth Momentum
Growth
EPS 1Y (TTM)40.62%
EPS 3Y16.56%
EPS 5Y27.85%
EPS Q2Q%22.96%
EPS Next Y10.56%
EPS Next 2Y12.12%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)25.69%
Revenue growth 3Y19.06%
Revenue growth 5Y16.43%
Sales Q2Q%31.95%
Revenue Next Year16.24%
Revenue Next 2Y15.06%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-0.02%
EBIT growth 3Y5.13%
EBIT growth 5Y20.49%
EBIT Next Year2.5%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y61.61%
FCF growth 3Y12.94%
FCF growth 5Y37.14%
OCF growth 1Y10%
OCF growth 3Y9.02%
OCF growth 5Y29.8%